首页 | 本学科首页   官方微博 | 高级检索  
     


Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study
Authors:Luca Cantarini  Rosaria Talarico  Elena Generali  Giacomo Emmi  Giuseppe Lopalco  Luisa Costa  Elena Silvestri  Francesco Caso  Rossella Franceschini  Rolando Cimaz  Florenzo Iannone  Mauro Galeazzi  Carlo Selmi
Affiliation:1. Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Beh?et's Disease Clinic, University of Siena, Siena, Italy;2. Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy;3. Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano, Milan, Italy;4. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy;5. Interdisciplinary Department of Medicine, Rheumatology Unit, Policlinic Hospital, University of Bari, Bari, Italy;6. Department of Clinical Medicine and Surgery, Rheumatology Unit, University Federico II, Naples, Italy;7. Department of Clinical Medicine, Rheumatology Unit, DIMED, University of Padua, Padua, Italy;8. Ophthalmology and Neurosurgery Department, University of Siena, Siena, Italy;9. Department of Pediatrics, Rheumatology Unit, Anna Meyer Children's Hospital and University of Florence, Florence, Italy;10. BIOMETRA Department, University of Milan, Milan, Italy
Abstract:
Keywords:anakinra  biotherapies  canakinumab  interleukin‐1 (IL‐1)  tumor necrosis factor (TNF)‐alpha
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号